Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.
about
Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infectionEffect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa.Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Azithromycin increases survival and reduces lung inflammation in cystic fibrosis miceDoxycycline attenuated pulmonary fibrosis induced by bleomycin in mice.State of progress in treating cystic fibrosis respiratory disease.Randomised trial of erythromycin on the development of chronic lung disease in preterm infantsRelationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosisChlamydia trachomatis growth stimulates interleukin 8 production by human monocytic U-937 cells.Nitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells.Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration.Erythromycin and diffuse panbronchiolitisPathogen- and host-directed anti-inflammatory activities of macrolide antibioticsRole of macrolide therapy in chronic obstructive pulmonary disease.Essential role of transcription factor nuclear factor-kappaB in regulation of interleukin-8 gene expression by nitrite reductase from Pseudomonas aeruginosa in respiratory epithelial cellsAzithromycin inhibits mucus hypersecretion from airway epithelial cells.Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole bloodNitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells.Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors.Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.Fourteen-member macrolides suppress interleukin-8 production but do not promote apoptosis of activated neutrophils.Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages.Inhibitory effect of erythromycin on interleukin 8 production by 1 alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells.Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes.Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor.Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats.Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression.Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.
P2860
Q33605247-E1B9D7CF-9575-4C71-908C-2DA0994CDD30Q33692226-D8FBD3FB-DB2E-4AC9-AAF7-D73DFDDFB469Q33978028-D6543931-A6CD-40BF-B473-192FCA902F6FQ33983140-6024E4BF-F324-4EC4-B92A-D6A0C4F844FBQ34185975-97B73649-C361-4630-BF23-67799A1BA2B6Q34352045-8E4BE22D-D0F3-423B-BF59-485778D08E04Q34375926-31B17A11-4C80-4A63-8977-2B34E751716EQ35286399-42641C2B-6A89-4A21-9639-E23F88E9BE64Q35385336-129FAF1F-D354-472B-AB10-BC3A01C66C51Q35532901-BE432CCC-83C9-435D-B778-E79EE90B1740Q35549782-B86D5994-5E9C-43CD-B227-9992E282C8D7Q35550634-29545C55-ED95-4E54-AECC-B62B39ACD35BQ35553784-976B9179-941E-44E6-98F0-AD9A78879B65Q35563192-5D235D10-7E83-4812-8953-D0D3ABC13365Q36072425-6E07FFB4-D20B-4009-8729-D55414DF842AQ37319950-1C06572C-2F65-4C3D-9427-158484449F9CQ39269144-682D4771-5B3F-46C3-BC60-1E8F6D899960Q39350133-B6FE4C2D-E9B2-4AE3-9EAE-34A58639E192Q39439981-EA3CD5C7-2913-4A7A-9192-58DF7EC40E33Q39470492-38D73DCC-11E5-4662-B39F-4AD3795239A6Q39470569-6E511F58-8BF0-4FFA-B29A-6CD2E3B6FFD4Q39476189-DF914FBA-BDE2-40BC-AD2D-B2E0451361A6Q39536134-E7CB7BAE-2554-4755-8158-FD0AA064AE71Q39611484-B411DFC4-535A-4F0B-ADA7-F66A7F64F57AQ39782346-CF4DDEE8-80ED-4D61-B25B-FFA13A07AB8FQ42112012-591AEC07-8F7C-4096-B836-9100F67B8FABQ42743425-6A003746-7201-49BD-9848-B9306EE48959Q43061206-473A04E5-E24A-4A32-9D99-CCE870EC3C3BQ43261580-02D143B0-6448-4272-9E3B-BAA19C3142ABQ45745775-E3CA61EA-2A76-46A3-9530-EEE5D4DD7C47Q55315278-97335B42-91CF-4A4F-AA03-6F48186A4249
P2860
Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@ast
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@en
Role of interleukin-8
@nl
type
label
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@ast
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@en
Role of interleukin-8
@nl
prefLabel
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@ast
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@en
Role of interleukin-8
@nl
P2093
P2860
P1476
Role of interleukin-8 (IL-8) a ...... with chronic airway diseases.
@en
P2093
Kobayashi S
Matsumoto K
Matsushima K
Nagatake T
P2860
P304
P407
P577
1994-10-01T00:00:00Z